Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.51%44 PS Ratio is 1.57 as of Jul. 24, 2026, which is 45% below its 10-year median of 2.83. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 930 Biotechnology companies, Synbio Tech ranks better than 87.42% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Synbio Tech's share price is NT$48.70.
Synbio Tech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$31.10. Hence, Synbio Tech's PS Ratio for today is 1.57.
Good Sign:
Synbio Tech Inc stock PS Ratio (=1.56) is close to 3-year low of 1.51.
The historical rank and industry rank for Synbio Tech's PS Ratio or its related term are showing as below:
ROCO:1295'
s PS Ratio Range Over the Past 10 Years
Min: 1.51 Med: 2.83 Max: 12.29
Current: 1.57
During the past 6 years, Synbio Tech's highest PS Ratio was 12.29. The lowest was 1.51. And the median was 2.83.
ROCO:1295's PS Ratio is ranked better than 87.42% of 930
companies
in the Biotechnology industry
Industry Median: 9.22
vs ROCO:1295: 1.57
Synbio Tech Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Synbio Tech was -0.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 9.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.60% per year.
During the past 6 years, Synbio Tech's highest 3-Year average Revenue per Share Growth Rate was 9.90% per year. The lowest was 3.60% per year. And the median was 4.60% per year.
Back to Basics: PS Ratio
Synbio Tech (ROCO:1295) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Synbio Tech PS Ratio Related Terms
Synbio Tech PS Ratio Historical Data
* Premium members only.
The historical data trend for Synbio Tech's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: PS Ratio Comparison
For the Biotechnology subindustry, Synbio Tech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's PS Ratio distribution charts can be found below:
* The bar in red indicates where Synbio Tech's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Synbio Tech's Share Price of today is NT$48.70. Synbio Tech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$31.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Synbio Tech (ROCO:1295) has a PS Ratio of 1.57 as of Jul. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Synbio Tech and its competitors. This is 45% below median its historical median of 2.83. Over the past decade, Synbio Tech's PS Ratio has ranged from 1.51 to 12.29. According to the industry distribution chart, Synbio Tech ranks #117 out of 930 companies in the Biotechnology industry, placing it in the top 12.6%.
Is Synbio Tech's PS Ratio too high?
Synbio Tech's current PS Ratio of 1.57 is 45% below median its 10-year median of 2.83. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 12.29. The Biotechnology industry median PS Ratio is 9.22. Synbio Tech's value of 1.57 is 83% below this industry median. Based on the distribution chart, Synbio Tech ranks #117 out of 930 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #117 out of 930 companies for PS Ratio. This places Synbio Tech in the top 13% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.22. Synbio Tech's value of 1.57 is 83% below this benchmark. Historically, Synbio Tech's own PS Ratio has ranged from 1.51 to 12.29 over the past decade. While the company's 10-year median is 2.83 vs. the industry median of 9.22, Synbio Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.22, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synbio Tech's current PS Ratio of 1.57 is 83% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median PS Ratio is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current PS Ratio is 1.57, which is 45% below median its own 10-year median of 2.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current PS Ratio of 1.57. The current PS Ratio is 1.57, which is 45% below median its 10-year median of 2.83 and 83% below the Biotechnology industry median of 9.22. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current PS Ratio is 1.57 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
